In conclusion, our study found that SNHG17 promoted the proliferation, migration, invasion and stemness of astrocytoma cells via targeting miR-876-5p/ERLIN2 pathway. This evidence concerns the gene ERLIN2 and astrocytoma (excluding glioblastoma).